NCT06438822View on ClinicalTrials.gov

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

August 30, 2026

Study Completion Date

November 30, 2026

Conditions
Cholangiocarcinoma
Interventions
COMBINATION_PRODUCT

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil

cadonilimab at a dosage of 6 mg/kg on day 1 combined with intravenous liposomal irinotecan at a dosage of 70 mg/m2 for 90 min on day 1 plus leucovorin at a dosage of 400 mg/m2 for 30 min on day 1 and fluorouracil at a dosage of 2400 mg/m2 for 46 h every 2 weeks.

Trial Locations (1)

610041

RECRUITING

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER